Avenida Henrique Duque Estrada Mayer 953
Bairro da Posse, 953, Nova Iguacu
Rio de Janeiro, 26030-380
HIV (and comorbidities)
A5332: REPRIEVE Trial
In this study, people between the ages of 40 and 75 with HIV will be randomized (like flipping a coin) to take the pill pitavastatin OR a placebo (non-active pill) to see if pitavastatin can help prevent heart disease and death in people who are taking HIV medication. You will not know if you are taking pitavastatin or placebo. The REPRIEVE trial will enroll about 7500 people from several countries.